US · Healthcare

Collegium Pharmaceutical Inc (COLL)

Drug Manufacturers - Specialty & Generic

Collegium Pharmaceutical Inc (COLL) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for COLL

P/E ratio

18.00

Collegium Pharmaceutical Inc (COLL) — FAQ

What is COLL's P/E ratio?

The price-to-earnings (P/E) ratio for Collegium Pharmaceutical Inc (COLL) is 18.00 (data as of 2026-03-24).

Does Collegium Pharmaceutical Inc pay a dividend?

Dividend yield is not available in the current snapshot for Collegium Pharmaceutical Inc (COLL). Check the MyAverix Finance app for the latest dividend data.

What sector is Collegium Pharmaceutical Inc in?

Collegium Pharmaceutical Inc (COLL) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is COLL listed on?

COLL is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)